Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System
Affiliations
The neuropeptide nociceptin/orphanin FQ (N/OFQ) can be released by stressors and is associated with disorders of emotion regulation and reward processing. N/OFQ and its receptor, NOP, are enriched in dopaminergic pathways, and intra-ventricular agonist delivery decreases dopamine levels in the dorsal striatum, nucleus accumbens (NAc), and ventral tegmental area (VTA). We used whole-cell electrophysiology in acute rat midbrain slices to investigate synaptic actions of N/OFQ. N/OFQ was primarily inhibitory, causing outward currents in both immunocytochemically identified dopaminergic (tyrosine hydroxylase positive (TH(+))) and non-dopaminergic (TH(-)) VTA neurons; effect at 1 μm: 20 ± 4 pA. Surprisingly, this effect was mediated by augmentation of postsynaptic GABAR currents, unlike the substantia nigra pars compacta (SNc), where the N/OFQ-induced outward currents were K channel dependent. A smaller population, 17% of all VTA neurons, responded to low concentrations of N/OFQ with inward currents (10 nm: -11 ± 2 pA). Following 100 nm N/OFQ, the response to a second N/OFQ application was markedly diminished in VTA neurons (14 ± 10% of first response) but not in SNc neurons (90 ± 20% of first response). N/OFQ generated outward currents in medial prefrontal cortex (mPFC)-projecting VTA neurons, but inward currents in a subset of posterior anterior cingulate cortex (pACC)-projecting VTA neurons. While N/OFQ inhibited NAc-projecting VTA cell bodies, it had little effect on electrically or optogenetically evoked terminal dopamine release in the NAc measured with fast scan cyclic voltammetry (FSCV). These results extend our understanding of the N/OFQ system in brainstem circuits implicated in many neurobehavioral disorders.
Zhou X, Stine C, Prada P, Fusca D, Assoumou K, Dernic J Nat Commun. 2024; 15(1):5353.
PMID: 38918403 PMC: 11199706. DOI: 10.1038/s41467-024-49712-0.
Petrella M, Borruto A, Curti L, Domi A, Domi E, Xu L Neuropharmacology. 2024; 248:109866.
PMID: 38364970 PMC: 11094429. DOI: 10.1016/j.neuropharm.2024.109866.
Zhou X, Stine C, Prada P, Fusca D, Assoumou K, Dernic J bioRxiv. 2023; .
PMID: 37292957 PMC: 10245933. DOI: 10.1101/2023.05.26.542102.
Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport.
Mazzeo F, Meccariello R, Guatteo E Int J Mol Sci. 2023; 24(9).
PMID: 37175536 PMC: 10178540. DOI: 10.3390/ijms24097831.
Coutens B, Ingram S Neuropharmacology. 2022; 226:109408.
PMID: 36584882 PMC: 9898207. DOI: 10.1016/j.neuropharm.2022.109408.